Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction.

Kuan Ken Lee, Anda Bularga, Rachel O'Brien, Amy V. Ferry, Dimitrios Doudesis, Takeshi Fujisawa, Shauna Kelly, Stacey Stewart, Ryan Wereski, Denise Cranley, Edwin J.R. van Beek, David J. Lowe, David E. Newby, Michelle C. Williams, Alasdair J. Gray, Nicholas L. Mills

Research output: Contribution to journalArticlepeer-review

Abstract

Background
Patients with suspected acute coronary syndrome in whom myocardial infarction has been excluded are at risk of future adverse cardiac events.

Objectives
This study evaluated the usefulness of high-sensitivity cardiac troponin I (hs-cTnI) to select patients for further investigation after myocardial infarction has been excluded.

Methods
This is a prospective cohort study of patients presenting to the emergency department with suspected acute coronary syndrome and hs-cTnI concentrations below the sex-specific 99th percentile. Patients were recruited in a 2:1 fashion, stratified by peak hs-cTnI concentration above and below the risk stratification threshold of 5 ng/L. All patients underwent coronary computed tomography angiography (CCTA) after hospital discharge.

Results
Overall, 250 patients were recruited (61.4 ± 12.2 years 31% women) in whom 62.4% (156 of 250 patients) had coronary artery disease (CAD). Patients with intermediate hs-cTnI concentrations (between 5 ng/L and the sex-specific 99th percentile) were more likely to have CAD than those with hs-cTnI concentrations <5 ng/L (71.9% [120 of 167 patients] vs 43.4% [36 of 83 patients]; odds ratio: 3.33; 95% CI: 1.92-5.78). Conversely, there was no association between anginal symptoms and CAD (63.2% [67 of 106 patients] vs 61.8% [89 of 144 patients]; odds ratio: 0.92; 95% CI: 0.48-1.76). Most patients with CAD did not have a previous diagnosis (53.2%; 83 of 156 patients) and were not on antiplatelet and statin therapies (63.5%; 99 of 156 patients) before they underwent CCTA.

Conclusions
In patients who had myocardial infarction excluded, CAD was 3× more likely in those with intermediate hs-cTnI concentrations compared with low hs-cTnI concentrations. In such patients, CCTA could help to identify those with occult CAD and to target preventative treatments, thereby improving clinical outcomes.
Original languageEnglish
Pages (from-to)1407–1417
JournalJournal of the American College of Cardiology
Volume78
Issue number14
Early online date27 Sept 2021
DOIs
Publication statusPublished - Oct 2021

Keywords / Materials (for Non-textual outputs)

  • acute coronary syndrome
  • coronary computed tomography angiogram
  • troponin

Fingerprint

Dive into the research topics of 'Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction.'. Together they form a unique fingerprint.

Cite this